Stocks and InvestingStocks and Investing
Thu, May 6, 2021
Wed, May 5, 2021
Tue, May 4, 2021
Mon, May 3, 2021

Daniel Busby Reiterated (ABBV) at Buy and Held Target at $135 on, May 3rd, 2021


Published on 2024-10-27 16:30:20 - WOPRAI, Daniel Busby
  Print publication without navigation


Daniel Busby of RBC Capital, Reiterated "AbbVie Inc." (ABBV) at Buy and Held Target at $135 on, May 3rd, 2021.

Daniel has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 0 agree with Daniel's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Daniel


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $144 on, Tuesday, March 30th, 2021
  • Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $125 on, Friday, March 12th, 2021
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $135 on, Thursday, February 4th, 2021
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021